drugset / Trial / NCT00004488
Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease
RandomizedSingle-groupDouble-blindTreatment
Summary
OBJECTIVES: I. Determine the efficacy of alendronate sodium in treating osteopenia (generalized bone density and focal bone lesions) in patients with Gaucher's disease.
Timeline
- Start
- 1998-10
- Primary completion
- —
- Completion
- 2002-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alendronic Acid | Small molecule | — | Oral |
| Background | Calcium carbonate | Other / unclassified | — | Oral |
| Background | Cholecalciferol | Other / unclassified | — | Oral |